Selected Recent Articles

• Methadone Users May Need Education About Hepatitis C Treatment.  (September 2016, Hepmag)
• ACLU, Harvard Law Sue Colorado for Restricting Access to Hepatitis C Treatment.  (September 2016, Hepmag)
• Hepatitis C Treatment: Getting It and Paying for It.  (September 2016, Hepmag)
• U.S. Hepatitis C Population Isn’t Getting the Care It Needs.  (September 2016, Hepmag)
• Study Supports Removal of Drug Use as Restriction for Hepatitis C Treatment.  (August 2016, Hepmag)
• How Telemedicine Can Bridge the Gaps in Hepatitis C Care.  (August 2016, Poz; related coverage in Hepmag)
• HCV Patients Face Obstacles to Treatment.  (August 2016, MedPage Today)
• Treating All People With Hepatitis C on Medicaid Would Save Money. (August 2016, Hepmag)
• Curing Hepatitis C Is Cheaper with Harvoni Than with Older Regimens.  (July 2016, Hepmag)
• Hepatitis C Treatment Access Is Opening Up Across the Country.  (July 2016, Hepmag)
• Telemedicine May Be the Future of Hepatitis C Care.  (June 2016, Hepmag)
• Hepatitis C antigen testing could eliminate need for two-step HCV testing, reduce cost of access.  (June 2016, AIDSmap)
• Strategies for improving the hepatitis C care continuum for people who inject drugs.  (June 2016, CATIE)
• Australia shows an alternative to rationing hepatitis C treatment.  (June 2016, AIDSmap)
• Despite New Medi-Cal Rules, Hepatitis C Treatment Is Hard to Come by in California.  (June 2016, Hepmag)
• New Funding to Support Curing Hep C Among People of Color Living with HIV.  (June 2016, Poz)
• New HCV therapies unaffordable to health systems and individuals.  (June 2016, AIDSmap)
• Pricey Hepatitis C Drugs Out of Reach for Many Worldwide.  (June 2016, Hepmag)
• Sofosbuvir/ledipasvir regimens can cost less per cure than older hepatitis C treatments.  (June 2016, AIDSmap)
• Federal Judge Orders Washington Medicaid to Stop Limiting Hepatitis C Treatment.  (June 2016, Hepmag)
• France to provide universal access to hepatitis C treatment.  (June 2016, AIDSmap)
• Generic hep C drugs as effective as high-cost brand names, plus other European Liver Conference highlights.  (May 2016, Beta Blog)
• Hepatitis C is Killing Americans in Record Numbers While Patients Cannot Access Life Saving Medicine.  (May 2016, Hepmag)
• New York Insurers Agree to Ease Restrictions on Hepatitis C Treatment.  (May 2016, Hepmag)
• Generic Hepatitis C Drugs Appear Highly Effective.  (April 2016, Hepmag)
• New York Attorney General Sues Albany Insurer for Restricting Access to HCV Treatment.  (April 2016, Hepmag)
• High Cure Rates Using Generic Hepatitis C Drugs Bought Online: EASL Supports Lower Cost Access for Western Countries.  (April 2016, HIV i-base); related coverage from Poz
• $300 hepatitis C combination to enter clinical trials.  (April 2016, AIDSmap)
• Identifying People Who Don’t Know They Are Infected with Hepatitis C.  (April 2016, Hepmag)
• Coinfection with HIV, HCV may simplify access to antiviral treatment.  (April 2016, Healio)
• Low-cost generic hepatitis C drugs match branded products in viral response.  (April 2016, AIDSmap)
• Eliminating Hepatitis B & C is Feasible, But What Will it Take to Achieve this Goal?  (April 2016, NASTAD)
• Primary care doctors and nurse practitioners can successfully treat people with hepatitis C.  (April 2016, AIDSmap); additional related coverage from AIDSmap
• Hepatitis C Tourism Surges Between China and India.  (April 2016, Hepmag)
• Delaying Hepatitis C Treatment May Increase Liver-Related Death Risk in Those with HIV.  (April 2016, Poz)
• Help Stop Insurers from Over-Charging Patients for Hepatitis B Drugs on the Healthcare Marketplace.  (April 2016, Hepmag)
• Harvard Analysis Alleges Health Insurance Discrimination Against People With HIV and Hepatitis C.  (April 2016, Poz)
• Accessing the Cure: Helping Patients With Hepatitis C Overcome Barriers to Care.  (March 2016, Project Inform)
• Hep C Screening Among Baby Boomers Is Inadequate, And Those With Medicaid Are Less Likely To Be Treated.  (March 2016, Hepmag)
• Urban Injection Drug Users Succeed on Hep C Treatment With Hands-On Care Protocol.  (March 2016, Poz)
• Kansas Legislators Want No Medicaid for Some with Hepatitis C.  (January 2016, Hepmag)
• Private Insurers Denied 1 in 4 Initial Requests for Harvoni in 2015.  (January 2016, Hepmag)
• Generic Sovaldi and Daklinza Could Be Made for Just $200 Per Cure.  (December 2015, Hepmag)
• DAAs could halt HCV epidemic in US – but only with near-universal testing and big increase in treatment rates.  (December 2015, AIDSmap)
• A quarter of people with HCV initially refused access to sofosbuvir/lepidasvir, says US study, but most successfully appeal.  (December 2015, AIDSmap)
• A New Look Behind the Pricing of a $1,000 Pill.  (December 2015, Hepmag)
• Natco Pharma to Make Generic Daklinza for Hepatitis C.  (December 2015, Hepmag)
• U.S. Hepatitis C Costs Fuel 6% Growth in Health Care Spending.  (December 2015, Hepmag)
• State Medicaid Restrictions for Hepatitis C Cures Are Creating One of America’s Worst Health Disparities.  (December 2015, Hepmag)
• U.S. Senate Report Criticizes Gilead for Hepatitis C Drug Costs.  (December 2015, Hepmag)
• Treating Hep C Earlier Is More Cost-Effective.  (December 2015, Hepmag)
• ACLU Sues Indiana for Restricting Hepatitis C Treatment.  (December 2015, Hepmag)
• BMS Offers Generic Daclatasvir for Hepatitis C in 112 Countries.  (December 2015, Hepmag)
• United States faces biggest burden of hepatitis C treatment costs before 2020.  (December 2015, AIDSmap)
• Social Security and Medicare Changes for 2016.  (December 2015, Poz)
• Insurance Woes.  (December 2015, Hepmag)
• Why We Should Be Willing to Pay for Hepatitis C Treatment.  (November 2015, Hepmag)
• Class Action Lawsuit Against Blue Cross for Denying Hepatitis C Treatment.  (November 2015, Hepmag)
• Hepatitis C Initiative in Ryan White Clinics Findings from a Special Program of National Significance.  (November 2015, Hepmag)
• Urgency of Hep C Treatment Rises as Fibrosis Advances.  (November 2015, Hepmag)
• Medicare Expected to Spend $9.2B on Hepatitis C Drugs in 2015.  (November 2015, Hepmag)
• Almost half of U.S. Medicaid recipients denied funding for hepatitis C treatment, 4-state study shows.  (November 2015, AIDSmap)
• Medicaid Disproportionately Denies Hepatitis C Therapy Coverage.  (November 2015, Hepmag)
• Express Scripts to Continue With AbbVie Hepatitis C Drugs.  (November 2015, Hepmag)
• The Dark Side of Letting Insurance Payers Dictate Hepatitis C Treatment.  (November 2015, Hepmag)
• Promising Approaches to Improving Outcomes along the HCV Continuum of Care.  (October 2015, Hepmag)
• U.S. study provides ‘real world’ evidence about which patients with hepatitis C should be prioritised for therapy.  (October 2015, AIDSmap)
• Interferon-free treatment works well for people who inject drugs, but barriers to access remain.  (October 2015, AIDSmap)
• Injection Drug Users With Hep C Should Get Treatment.  (October 2015, Hepmag)
• Gilead to Provide Free Hepatitis C Treatment in Iceland.  (October 2015, Hepmag)
• People who inject drugs should have access to hepatitis C treatment, expert panel recommends.  (October 2015, AIDSmap)
• Florida Insurers Cited for Alleged Hepatitis Discrimination.  (October 2015, Hepmag)
• What is the process for new hepatitis drugs to become available at pharmacies after FDA approval?  (October 2015, Hepmag)
• Rhode Island Medicaid Denied 65% of Hep C Treatment Requests in 2015.  (September 2015, Hepmag)
• Lack of Insurance Impedes Prompt Care After Hep C Diagnosis.  (September 2015, Hepmag)
• Medicines Patent Pool to Expand Global Hepatitis C Treatment.  (September 2015, Hepmag)
• Experts Urge More Medicaid Access to Hepatitis C Treatment.  (September 2015, Hepmag)
• Medicines Patent Pool looks at hepatitis C.  (September 2015, AIDSmap)
• Initial Insurance Denials of Hep C Drug Harvoni May Be Reversible.  (August 2015, Hepmag)
• The Need for a Codified Hepatitis C Care Continuum.  (August 2015, TheBodyPro.
• Concerns Over State Restrictions on New Hepatitis C Drugs.  (July 2015, Hepmag)
• China Rejects Patent for Hep C Drug Sovaldi.  (June 2015, Hepmag)
• Connecticut Cuts Costs of Hepatitis C Drugs Through Medicaid.  (June 2015, Hepmag)
• Veterans Affairs Plans to Outsource Hepatitis C Care.  (June 2015, Hepmag)
• Massachusetts Inmates Sue Prisons for Hepatitis C Treatment.  (June 2015, Hepmag)
• Hepatitis C Patients Take Extreme Measures for Cheaper Cures.  (June 2015, Hepmag)
• Inmates Sue Minnesota for Alleged Denial of Hepatitis C Drugs.  (May 2015, Hepmag)
• Sanders Urges Veterans Affairs to Break Hepatitis C Patents.  (May 2015, Hepmag)
• World Health Organization Throws Weight Behind Hep C Treatments.  (May 2015, Hepmag)
• California Woman Sues Insurer to Pay for Hepatitis C Treatment.  (May 2015, Hepmag)
• Hepatitis C treatment for people in prison may be highly cost-effective in England.  (May 2015, AIDSmap)
• Curing Hepatitis C Likely Spells Substantial Economic Benefit.  (May 2015, Hepmag)
• WHO Adds New Hepatitis C Drugs to Essential Medicines List.  (May 2015, Hepmag)
• Another study confirms detrimental effects of delaying hepatitis C treatment.  (May 2015, AIDSmap)
• Gilead to Give Country of Georgia Free Hepatitis C Treatment.  (April 2015, Hepmag)
• Hepatitis C Treatment Costs Threaten to Cripple Prison Budgets.  (April 2015, Hepmag)
• Is There Any Good Reason Left to Delay Hepatitis C Treatment?  (April 2015, Hepmag)
• Hep C Treatment Is Sometimes Cost-Effective for Genotypes 2 and 3.  (April 2015, Hepmag)
• Medicare Spent $4.5 Billion on New Hepatitis C Drugs in 2014.  (April 2015, Hepmag)
• Supervisor Wiener: Reclassifying HIV Drugs as “Specialty” is Discriminatory.  (March 2015, Beta Blog)
• A Community-based Program Successfully Engages Participants in Hepatitis C Care.  (March 2015, Hepmag)
• Hepatitis C – Both the Good News and Bad.  (March 2015, Beta Blog)
• Harvoni Is Mostly Cost Effective, But Budget Impact Will Be Huge.  (March 2015, Hepmag)
• $10 Per Pill Unauthorized Generic Sovaldi Being Sold in Bangladesh.  (March 2015, Hepmag)
• Pricey New Hep C Drugs Still Cheaper Per Cure Than Oldest Ones.  (March 2015, Hepmag)
• Indian Drugmaker Natco to Make Generic Hepatitis C Treatments.  (March 2015, Hepmag)
• Advocates Adapt Global HIV Strategy for Cheaper HCV Drugs.  (March 2015, Hepmag)
• Delaying Hep C Therapy for HIV/HCV Coinfected People Is Risky.  (March 2015, Poz)
• Hepatitis C, the costs of treatment, the costs of delay, and the case for action.  (March 2015, Science Speaks Blog)
• Average cost per SVR12 was $171,000 for Olysio, Sovaldi regimens.  (March 2015, Healio)
• Delay HCV Tx and Watch Patients Die.  (March 2015, MedPage Today)
• Delayed HCV therapy may increase liver-related deaths.  (February 2015, Healio)
• People With Hep C May Stick With Meds Better If Care Is Personalized.  (February 2015, Hepmag)
• amfAR Report Examines Hepatitis C Drug Pricing Controversy.  (February 2015, Hepmag)
• Success for a Program to Help Get People With Hep C Into Care.  (February 2015, Hepmag)
• Denied Hepatitis C Treatment? Here is How to Fight Back.  (February 2015, Hepmag)
• UnitedHealth Prioritizes Hepatitis C Drug Harvoni.  (February 2015, Hepmag)
• FDA Intends to Rescind Breakthrough Status for Merck Hep C Therapy.  (February 2015, Hepmag)
• Aetna Gives Priority to Hepatitis C Drugs Sovaldi and Harvoni.  (January 2015, Hepmag)
• Indian Manufacturers to Make Cheaper, Generic Sovaldi After Patent Rejection.  (January 2015, Hepmag)
• Humana Prioritizes Hepatitis C Drugs Sovaldi and Harvoni.  (January 2015, Hepmag)
• Prime Therapeutics Gives Priority to Harvoni and Viekira Pak.  (January 2015, Hepmag)
• Hepatitis C Drug Victrelis (Boceprevir) Gets Pulled by Manufacturer.  (January 2015, Project Inform)
• ADAP Crisis Task Force Negotiates Discount on Viekira Pak.  (January 2015, Hepmag)
• VA and DOD Spent Nearly $500M Treating Hepatitis C in 2014.  (January 2015, Hepmag)
• Anthem Also Prioritizes Sovaldi and Harvoni Over Viekira Pak.  (January 2015, Hepmag)
• CVS to Prioritize Sovaldi and Harvoni Over Viekira Pak.  (January 2015, Hepmag)
• 2014 Viral Hepatitis Year-in-Review and Looking to 2015.  (January 2015, Hepmag)
• People With Hepatitis C Often Get Lost in the Health Care Shuffle.  (January 2015, Hepmag)
• U.S. Hepatitis C Patients Lost to Care at Different Stages of Care.  (December 2014, Hepmag)
• U.S. Congress Meets Again to Discuss Hepatitis C Drug Pricing.  (December 2014, Hepmag)
• New HCV Option Effective, Safe, Well-Tolerated – and Use Will Likely Be Driven by Payors. (December 2014, Journal Watch)
• Major Pharmacy Group Will Prioritize AbbVie’s Hep C Regimen.  (December 2014, Hepmag)
• One million people with hepatitis C in the US at high priority for treatment.  (December 2014, AIDSmap)
• SEPTA Seeks Federal Class Action Lawsuit Over Sovaldi Pricing.  (December 2014, Hepmag)
• Hep C Treatment Guidelines Prioritize Care.  (December 2014, Hepmag)
• Hep C Hospitalizations and Related Costs Are On the Rise.  (December 2014, Hepmag)
• France Secures Lowest Price for Sovaldi in All of Europe.  (December 2014, Hepmag)
• US activists called on Gilead to set a per-treatment price for sofosbuvir/ledipasvir.  (November-December 2014, HIV Treatment Bulletin)
• What 2014 Development Has the Biggest Impact on HIV Care?  (November 2014, TheBodyPro)
• Alleged Misuse of Sovaldi for Hepatitis C Genotype 4 in Egypt.  (November 2014, Hepmag)
• The Thorny Economics of Treating Inmates Hep C With Sovaldi.  (November 2014, Hepmag)
• Express Scripts May Swap Sovaldi for Cheaper AbbVie Combo.  (October 2014, Hepmag)
• Hep C Treatment Guidelines Re-Stress That Treatment Is for All.  (October 2014, Hepmag)
• ‘Pay If You Clear’ Program Proposed for Olysio in Scotland.  (October 2014, Hepmag)
• Advocates Criticize Plans to Restrict N.Y. Hepatitis C Drugs.  (October 2014, Hepmag)
• Fair Pricing Coalition Seeks Uniform Price for Harvoni Treatment.  (October 2014, Hepmag)
• Fair Pricing Coalition Welcomes Approval of Gilead Sciences’ Combination Tablet for Hepatitis C, Urges a Uniform Price for Curative Treatment.  (October 2014, Fair Pricing Coalition)
• France to Tax Hepatitis C Drug Makers to Encourage Price Cuts.  (October 2014, Hepmag)
• Hepatitis C: Treating Those at High Risk.  (October 2014, Hepmag)
• Australia Refuses to Subsidize Hepatitis C Sovaldi Treatment.  (October 2014, Hepmag)
• Only 10% of veterans with HCV or HCV/HIV in the U.S. treated for HCV. (September/October 2014, HIV Treatment Bulletin)
• Sofosbuvir/Ledipasvir Combo Pill Potentially Pricier Than Sovaldi.  (September 2014, Hepmag)
• Indian Drug Makers to Sell Generic Sovaldi to 91 Poor Countries.  (September 2014, Hepmag)
• What Kind of Doctor Should You See For Hepatitis C Treatment?  (September 2014,Poz)
• Advocates Urge HHS to End Barriers to Hep C Treatment.  (September 2014, Hepmag)
• Primary Care Docs Clueless About Hep C Drugs.  (September 2014, Hepmag)
• HIV Clinicians Excluded From Prescribing Hepatitis C Treatment.  (September 2014, Hepmag)
• ACT UP Letter Asks U.S. Senate to Negotiate Sovaldi Price Cut.  (August 2014, Hepmag)
• Hep C Meds Could Increase Federal Medicare Spending $3B by 2015.  (August 2014, Hepmag)
• New Hep C Meds Could Spell Disaster for U.S. Prison Budgets.  (August 2014, Hepmag)
• Gilead’s Hep C Cure Was Initially Pitched to Be Half the Price.  (August 2014, Hepmag)
• U.S. Senate investigate Gilead for sofosbuvir price: potential to bankrupt Federal healthcare and add $300 annually to every American insurance premium for the next five years.  (August 2014, HIV i-Base)
• Hep C Drugs Could Add $300 to Everyone’s Yearly Insurance Premium.  (July 2014, Hepmag)
• Should Congress Free Medicare to Negotiate Drug Prices?  (July 2014, Hepmag)
• U.S. Senate Opens Investigation on Price of Hep C Drug Sovaldi.  (July 2014, Poz)
• Gilead Reaps $3.48 Billion in Second Quarter Sovaldi Sales.  (July 2014, Poz)
• Just 9 Percent of Americans With Hep C Have Been Cured.  (July 2014, Poz)
• New Analysis Identifies Major Gaps in Hep C Health Care.  (July 2014, Hepmag)
• The Price of NOT Curing Hepatitis C.  (July 2014, Poz)
• Egypt Will Get Sovaldi for $300 Per Treatment.  (July 2014, Poz)
• EU Nations Team Up to Lower Price of New Hep C Drug.  (July 2014, Poz)
• Push Back Against Expensive Medicines.  (July 2014, Hepmag)
• CDC Adopts Health IT, Telemedicine to Combat Hepatitis Epidemic.  (June 2014, Hepmag)
• Poll: 75% of Primary Care Docs Unaware of New Hep C Meds.  (June 2014, Hepmag)